Related Experiment Video

Updated: Jul 11, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Inhibitor kappaB kinase beta binding by inhibitor kappaB kinase gamma

Devin Drew1, Eriko Shimada, Kim Huynh

  • 1Department of Chemistry & Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.

Biochemistry
|October 11, 2007
PubMed

Insights

Researchers identified the specific regions of IKKgamma and IKKbeta proteins that bind, revealing a high-affinity interaction crucial for the nuclear factor kappaB pathway. This clarifies the molecular basis of the inhibitor kappaB kinase complex assembly.

Area of Science:

  • Molecular Biology
  • Protein Kinase Signaling
  • Transcription Factor Regulation

Background:

  • The inhibitor kappaB kinase (IKK) complex is essential for activating nuclear factor kappaB (NF-κB) transcription factors.
  • The IKK complex consists of catalytic subunits (IKKα, IKKβ) and a regulatory subunit (IKKγ).
  • IKKβ and IKKγ associate via IKKγ's N-terminus and IKKβ's C-terminal peptide.

Purpose of the Study:

  • To pinpoint the minimal IKKγ segment responsible for IKKβ binding.
  • To quantify the binding affinity of the IKKβ/IKKγ complex.
  • To investigate the structural behavior of IKK subunits and their complex.

Main Methods:

  • Protein truncation and deletion mutagenesis of IKKγ.
  • Analysis of IKKβ C-terminal domain interactions.
  • Determination of binding affinity using dissociation constant (Kd) measurements.
  • Solution behavior analysis of IKKγ fragments and IKKβ C-terminal domain.

Main Results:

  • The N-terminal segment of IKKγ (residues 40-130) binds the IKKβ C-terminal domain (residues 665-756) with a Kd of approximately 25 nM.
  • Smaller IKKγ N-terminal deletion mutants exhibited aggregation and covalent complex formation.
  • Extending IKKγ fragments to residue 210 stabilized their solution behavior without altering IKKβ binding affinity.
  • The IKKβ C-terminal domain dimerizes in solution, forming a dimer/dimer as the fundamental unit of the IKKβ/IKKγ complex.

Conclusions:

  • The study precisely defines the molecular interface between IKKγ and IKKβ.
  • Understanding this interaction is key to modulating NF-κB pathway activity.
  • The dimeric nature of the IKKβ C-terminus influences the overall IKK complex structure and function.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...